Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
The FDA continues to advance new policies, modernize programs and advance opportunities for developing more targeted therapies. Using new technology platforms such as cell and gene therapies and small molecule drugs that target the genomic basis of disease, there are more opportunities to intervene in the underlying mechanisms that cause a disease, and potentially arrest and even reverse its progress.
A report published today by the European Medicines Agency (EMA) shows that the overall sales of veterinary antimicrobials across Europe have decreased by more than 20% between 2011 and 2016. This continues the downward trend seen over the last few years and confirms that European Union (EU) guidance and national campaigns promoting prudent use of antibiotics in animals to fight antimicrobial resistance are having a positive effect.
EU authorities are placing the Chinese company Zheijiang Huahai under increased supervision following European and US inspections which revealed weaknesses in quality management at the company’s Chuannan site in Linhai, China.
[adsense:336x280:8701650588]
In yet another landmark step to strengthen the food safety and nutrition ecosystem in the country, the government formally notified the very first set of Recruitment Regulations of the Food Safety and Standards Authority of India (FSSAI) in the official gazette on 11.10.2018. This follows closely on the heels of another important milestone a few weeks ago, when almost 500 new posts were created to strengthen the functioning of the Authority.
A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications.
Following a meeting in Delhi earlier this month, MHRA will send intelligence to the Directorate of Revenue Intelligence (DRI), enabling them to target regions suspected of sending unlicensed medicines into the UK.
The U.S. Food and Drug Administration approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types. ID CORE XT is the second molecular assay approved for use in transfusion medicine, and the first to report genotypes as final results.
At the function, Shri J P Naddareleased the Position Paper and launched the Information Sharing Platform Gateway for South-East Asia Regulatory Network (SEARN) developed by Centre for Development of Advanced Computing, which will promote regulatory and health collaboration among the countries of the South-East Asia Region.
The Union Health Minister stated that access to medical products and creating an enabling legal and trade environment for public health are critical to achieving the Sustainable Development Goals 2030 Agenda.
“India is deeply committed nationally and globally to achieving all public health goals. Together we are working towards providing highest possible standards of health care for our citizens. Universal health coverage is key to the Sustainable Development Goals 2030 agenda and to which India is firmly committed.” This was stated by Shri J P Nadda, Union Minister of Health and Family Welfare during his address at the inauguration of ‘2nd World Conference on Access to Medical Products: Achieving the SDGs 2030’, here today.
Shri Ashwini Kumar Chaubey, Minister of State (HFW), Smt. Anupriya Patel, Minister of State (HFW), SmtPreeti Sudan, Secretary (Health), Dr.BalramBhargava, Secretary, Dept. of Health & Research (DHR) and DG, ICMR,Dr Mariângela Batista GalvãoSimão, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, WHO Geneva, Dr.PoonamKhetrapal Singh, Regional Director, WHO SEARO, Dr RK Vats, Additional Secretary, Health Ministry, andDr.HenkBekedam, WHO Representative to India, also graced the occasion.State Health Ministers and Principal Secretaries from several states in India were also present.
Speaking at the function, ShriNadda said that the National Health Policy 2017 is dedicated to the highest possible standards of health for the country. “The Government has launched Ayushman Bharat, a National Health Protection Scheme, which envisions health assurance of 5 lakh rupees (6815 USD) per family per year, will benefit over 50 crore (i.e. 500 million) people, and is the world's biggest health assurance scheme. He further added that since its launch on 23rd September, 2018, more than 50,000 people have availed of services under the scheme.
“These issues require continuous engagement and dialogue. I believe that the Health Ministry with active partnership of other ministries in Government of India will move forward in leaps and bounds,” he said. The Union Health Minister further added that India is actively contributing and providing support for the South-East Asia Regulatory Network (SEARN) to guarantee access to high-quality medical products.
Shri Ashwini Kumar Choubey, Minister of State for Health and Family Welfarehighlighted the importance of traditional medical system in achieving the health goals. He stated that strengthening R&D and upholding education standards in the Indian Systems of Medicines, promoting the cultivation of medicinal plants used, and working on Pharmacopoeia standards are areas with positive public health potential outcomes. “The diagnosis of modern medicine combined with the treatment modalities of the Ayurveda, Yoga, Homeopathy and other systems of AYUSH will help in giving a holistic approach to treatment,” ShriChoubey said.
Smt Anupriya Patel, Minister of State for Health and Family Welfare said that Sustainable Development Goals are the mantra for a better future for all and access to medicines is a critical factor for success of the SDG Agenda that aims to ensure healthy lives and promote well-being of all people of all ages. “Universal Health Coverage and access to medicines is also one of the regional flagship priorities for countries in the WHO South-East Asia region,” she added. She stated that India is committed to attainment of the highest possible standards of health for its citizens.
Dr TedrosAdhanomGhebreyesus, Director General, World Health Organization through his video address stated that WHO has embarked on the 13th Global Programme of Work (GPW13) for strategic direction in Sustainable Development Agenda 2030 (SDG) for health which is vital for the future of our world. GPW 13 is structured around the “triple billion” goal for three interconnected strategic priorities of Healthy Lives, Universal Health Coverage and health emergencies. ‘Reliable access to effective, safe, quality-assured and affordable medical products are keys to making progress towards Universal Health Coverage (UHC) and the SDGs,’ he said.
The main objective of the 2nd World Conference 2018 is to take forward the recommendations from the 1st World Conference 2017 and build on the work done for access to medical products in the context of SDGs (including trade agreements) in line with GPW 13 of WHO, foster new approaches in innovation landscape for medical products and health technologies for accelerating research and innovation and identify knowledge, information and policy options on the interface of international trade and health to achieve SDG 2030 goals.
PharmaTutor (www.pharmatutor.org) has received award as Best Pharma Career Portal and It's founder Mr. Rajesh Vagh honored with Eminent Pharmacist Award in an event on world pharmacist day, 25th September 2018, at ISF college of Pharmacy, Moga.
[adsense:336x280:8701650588]
The U.S. Food and Drug Administration approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
